These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38730601)

  • 21. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraductal carcinoma of the prostate: the whole story.
    Zhou M
    Pathology; 2013 Oct; 45(6):533-9. PubMed ID: 24018805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients.
    Jeyapala R; Kamdar S; Olkhov-Mitsel E; Zlotta A; Fleshner N; Visakorpi T; van der Kwast T; Bapat B
    Clin Genitourin Cancer; 2022 Jun; 20(3):e217-e226. PubMed ID: 35151601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraductal carcinoma of the prostate.
    Robinson B; Magi-Galluzzi C; Zhou M
    Arch Pathol Lab Med; 2012 Apr; 136(4):418-25. PubMed ID: 22458904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
    Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
    Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.
    Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U
    Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Kamihira O; Sano T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2020 Feb; 80(3):284-290. PubMed ID: 31860754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study.
    Watts K; Li J; Magi-Galluzzi C; Zhou M
    Histopathology; 2013 Oct; 63(4):574-9. PubMed ID: 23931616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.
    Zhao J; Sun G; Zhu S; Dai J; Chen J; Zhang M; Ni Y; Zhang H; Shen P; Zhao X; Zhang B; Pan X; Nie L; Yin X; Liang J; Zhang X; Wang Z; Zhu X; Liao B; Liu Z; Armstrong CM; Gao AC; Huang H; Chen N; Zeng H
    BJU Int; 2022 Mar; 129(3):345-355. PubMed ID: 34185954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate.
    Zhao J; Xu N; Zhu S; Nie L; Zhang M; Zheng L; Cai D; Sun X; Chen J; Dai J; Ni Y; Wang Z; Zhang X; Liang J; Chen Y; Hu X; Pan X; Yin X; Liu H; Zhao F; Zhang B; Chen H; Miao J; Qin C; Zhao X; Yao J; Liu Z; Liao B; Wei Q; Li X; Liu J; Gao AC; Huang H; Shen P; Chen N; Zeng H; Sun G
    Cancer Res; 2024 Jan; 84(1):154-167. PubMed ID: 37847513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
    van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
    Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
    Zhao T; Liao B; Yao J; Liu J; Huang R; Shen P; Peng Z; Gui H; Chen X; Zhang P; Zhu Y; Li X; Wei Q; Zhou Q; Zeng H; Chen N
    Prostate; 2015 Feb; 75(3):225-32. PubMed ID: 25307858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy.
    Zhao J; Shen P; Sun G; Chen N; Liu J; Tang X; Huang R; Cai D; Gong J; Zhang X; Chen Z; Li X; Wei Q; Zhang P; Liu Z; Liu J; Zeng H
    Oncotarget; 2017 Aug; 8(33):55374-55383. PubMed ID: 28903426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal carcinoma of prostate: a comprehensive and concise review.
    Roberts JA; Zhou M; Park YW; Ro JY
    Korean J Pathol; 2013 Aug; 47(4):307-15. PubMed ID: 24009625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis: a systematic review and meta-analysis.
    Zhang YC; Sun GL; Ma DL; Wei C; Shang HJ; Liu Z; Li R; Wang T; Wang SG; Liu JH; Liu XM
    Asian J Androl; 2021; 23(1):103-108. PubMed ID: 32496222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
    Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B
    Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer.
    Chen Z; Chen N; Shen P; Gong J; Li X; Zhao T; Liao B; Liu L; Liu Z; Zhang X; Liu J; Peng Z; Chen X; Xu M; Gui H; Zhang P; Wei Q; Zhou Q; Zeng H
    Prostate; 2015 Sep; 75(12):1247-54. PubMed ID: 25917338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait.
    Pantazopoulos H; Diop MK; Grosset AA; Rouleau-Gagné F; Al-Saleh A; Boblea T; Trudel D
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patients.
    Ito T; Takahara T; Taniguchi N; Yamamoto Y; Satou A; Ohashi A; Takahashi E; Sassa N; Tsuzuki T
    Pathol Int; 2023 Nov; 73(11):542-548. PubMed ID: 37608749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.